A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner

- Sutton, Selina K., Carter, Daniel R., McArthur, Grant A., Cheung, Belamy B., Marshall, Glenn M., Kim, Patrick, Tan, Owen, Arndt, Greg M., Zhang, Xu Dong, Baell, Jonathan, Noll, Benjamin D., Wang, Shudong, Kumar, Naresh

The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs

- Liu, Pei Y., Sokolowski, Nicholas, Liu, Bing, Yang, Rui H., Guo, Xiang Y., Tee, Andrew E., Itoh, Ken, Wang, Jenny, Kavallaris, Maria, Haber, Michelle, Norris, Murray D., Cheung, Belamy B., Guo, Su T., Byrne, Jennifer A., Ziegler, David S., Marshall, Glenn M., Dinger, Marcel E., Codd, Rachel, Zhang, Xu D., Liu, Tao, Siddiqi, Faraz, Atmadibrata, Bernard, Telfer, Thomas J., Sun, Yuting, Zhang, Lihong, Yu, Denise, Mccarroll, Joshua

The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35.

- Liu, Pei Y., Tee, Andrew E., Milazzo, Giorgio, Hannan, Katherine M., Maag, Jesper, Mondal, Sujanna, Atmadibrata, Bernard, Bartonicek, Nenad, Peng, Hui, Ho, Nicholas, Mayoh, Chelsea, Ciaccio, Roberto, Sun, Yuting, Henderson, Michelle J., Gao, Jixuan, Everaert, Celine, Hulme, Amy J., Wong, Matthew, Lan, Qing, Cheung, Belamy B., Zhang, Xu D.

TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells

- Sutton, Selina K., Koach, Jessica, Long, Georgina V., Liu, Tao, McArthur, Grant, Zhang, Xu Dong, Scolyer, Richard A., Cheung, Belamy B., Marshall, Glenn M., Tan, Owen, Liu, Bing, Carter, Daniel R., Wilmott, James S., Yosufi, Benafsha, Haydu, Lauren E., Mann, Graham J., Thompson, John F.